14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 80 days ( -71.67 % )
Last Price $0.80 0 %
High/ Low $0.80 - $0.80 0%
Chg 7 Days N/A $0.80 $0.80
Chg 30 Days N/A $0.80 $0.80
Chg 12 mos -52.38 % $1.68 $0.80
Trend - 3 mos 33.24 % Width: 56.33 %
Trend - 12 mos -58.37 % Width: 4,200.53 %
Pred. range - 3 mos $0.95 - $1.48 18.18 % - 84.76 %
Pred. range - 12 mos N/A - $0.393 -100.00 % - -50.85 %
Short MA avg 3 mos Sell Jun 17, 2022 - 42 days
Long MA avg 3 mos Sell Jul 26, 2022 - 17 days
Short/Long MA avg 3 mos Sell Jul 26, 2022 - 17 days
Short MA avg 12 mos Sell Jun 22, 2022 - 40 days
Long MA avg 12 mos Buy Jun 07, 2022 - 50 days
Short/Long MA avg 12 mos Buy Jun 15, 2022 - 44 days
Pivot Short Buy Jun 22, 2022 - 40 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About ZIOPHARM Oncology Inc

ZIOPHARM Oncology ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. The company, through its collaboration agreement with Intrexon Corporation, holds certain rights to Intrexon’s synthetic immuno-oncology platform for use in the field of oncology, which includes a clinical stage product candidate, Ad-RTS-IL-12 t... ZIOP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT